TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE

糖尿病血管疾病中的 TNF-α 和 BMP2-WNT 信号转导

基本信息

  • 批准号:
    7608622
  • 负责人:
  • 金额:
    $ 38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-15 至 2013-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Westernized societies are experiencing an epidemic of type II diabetes (T2DM), related to life-style, obesity, and longevity. T2DM is a systemic vascular disorder; wide-spread low grade arterial inflammation, elevated TNF-alpha levels, & oxidative stresses disrupt macrovascular (e.g., heart, aorta) & microvascular (e.g. retina, renal glomerulus) functions. A highly characteristic feature of T2DM is medial artery calcification (MAC). The negative consequences of reduced aortofemoral compliance of MAC have emerged; MAC perturbs normal Windkessel physiology, causing systolic & diastolic dysfunction that increases mortality & amputation risk. The ability to prevent or treat MAC represents an unmet clinical need. A better understanding of how diabetes and kidney disease (CKD) promote MAC will provide insights useful for devising new strategies to reduce vascular calcium load, preserve aortic compliance, & improve vascular function. Recent data have identified activated aortic BMP2-Msx2-Wnt signaling in diabetic MAC--all inhibited by infliximab. The chief goal of this project is to assess how targeting these signals can improve aortic calcification, structure, & compliance. Aim 1: "To test whether inhibition of arterial BMP2- Wnt induction with theTNF-alpha antagonist infliximab or salicylate improves aortic compliance in diabetic vascular disease." By assessing aortic pressure- diameter relationships using ex vivo video plethysmography, we will establish the relationships between TNF-alpha & aortic calcium accumulation, Wnt signaling, and stiffness in a relevant T2DM model--the TOPGAL+; LDLR-/- mouse fed diabetogenic high fat diets (HFD). Comparison will be made with responses to the RANKL inhibitor, OPG. Aim 2: "To characterize the mechanisms whereby TNF- alpha signaling via NADPH oxidase promotes Msx2 gene transcription in aortic adventitial myofibroblasts." The NAPDH oxidase inhibitor, apocynin, inhibits Msx2 induction by TNF-alpha (transcriptionally mediated). By identifying the signaling cascades conveying Msx2 induction in response to TNF-alpha, novel strategies can be devised to inhibit vascular calcification. Aim 3: "To identify if NADPH oxidase signaling is required for induction of aortic BMP2-Msx-2-Wnt cascades in T2DM, using p47phox- /-; TOPGAL+; LDLR-/- mice as a model." By phenotyping p47phox-/-; TOPGAL+; LDLR-/- and p47phox+/-;TOPGAL+; LDLR-/- controls, we assess whether this TNF- regulated redox pathway contributes to aortic BMP2-Msx2-Wnt activation by HFD.
描述(申请人提供):西方化社会正在经历II型糖尿病(T2 DM)的流行,这与生活方式、肥胖和长寿有关。T2 DM是一种全身性血管疾病;广泛分布的低度动脉炎症、升高的肿瘤坏死因子-α水平和氧化应激破坏了大血管(如心脏、主动脉)和微血管(如视网膜、肾小球)的功能。T2 DM的一个高度特征是内侧动脉钙化(MAC)。MAC的主-股顺应性降低的负面后果已经显现;MAC扰乱了正常的Windkesel生理,导致收缩和舒张期功能障碍,增加了死亡率和截肢风险。预防或治疗MAC的能力代表着一种未得到满足的临床需求。更好地了解糖尿病和肾脏疾病(CKD)是如何促进MAC的,将为设计新的策略以减少血管钙负荷、保持主动脉顺应性和改善血管功能提供有益的见解。最近的数据表明糖尿病患者的主动脉BMP2-MSX2-Wnt信号被激活,均被英夫利昔单抗抑制。该项目的主要目标是评估靶向这些信号如何改善主动脉钙化、结构和顺应性。目的1:“检测用肿瘤坏死因子-α拮抗剂英夫利昔单抗或水杨酸盐抑制动脉BMP2-WNT诱导是否能改善糖尿病血管病变患者的主动脉顺应性。”通过使用体外视频体积描记术评估主动脉压-直径关系,我们将在一个相关的T2 DM模型--TOPGAL+;LDLR-/-小鼠中建立肿瘤坏死因子-α与主动脉钙蓄积、Wnt信号和僵硬度之间的关系。将与RANKL抑制剂OPG的反应进行比较。目的2:研究肿瘤坏死因子-α通过NADPH氧化酶促进血管外膜成纤维细胞MSX2基因转录的机制。NAPDH氧化酶抑制剂载脂蛋白抑制肿瘤坏死因子-α(转录介导的)诱导的MSX2。通过识别传递MSX2诱导的信号级联反应对肿瘤坏死因子-α的反应,可以设计新的策略来抑制血管钙化。目的3:以p47Phox-/-、TOPGAL+、LDLR-/-小鼠为模型,研究2型糖尿病大鼠主动脉BMP2-MSX-2-Wnt级联反应是否需要NADPH氧化酶信号转导。通过分型p47Phox-/-;TOPGAL+;LDLR-/-和p47Phox+/-;TOPGAL+;LDLR-/-对照,我们评估了这种由肿瘤坏死因子调节的氧化还原途径是否参与了HFD对BMP2-MSX2-Wnt的激活。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DWIGHT A. TOWLER其他文献

DWIGHT A. TOWLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DWIGHT A. TOWLER', 18)}}的其他基金

Cdc42bpg signaling in arteriosclerosis and vascular fibrosis
动脉硬化和血管纤维化中的 Cdc42bpg 信号传导
  • 批准号:
    10448070
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
University of Texas Southwestern - Stimulating Access to Research in Residency (UT-StARR) Program
德克萨斯大学西南分校 - 促进住院医师研究 (UT-StARR) 计划
  • 批准号:
    10655275
  • 财政年份:
    2021
  • 资助金额:
    $ 38万
  • 项目类别:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
钙化性主动脉瓣硬化的内分泌调节:PTH/PTHRP 受体信号
  • 批准号:
    8597586
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
钙化性主动脉瓣硬化的内分泌调节:PTH/PTHRP 受体信号
  • 批准号:
    8856647
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
钙化性主动脉瓣硬化的内分泌调节:PTH/PTHRP 受体信号
  • 批准号:
    8535817
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
钙化性主动脉瓣硬化的内分泌调节:PTH/PTHRP 受体信号
  • 批准号:
    8697129
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
钙化性主动脉瓣硬化的内分泌调节:PTH/PTHRP 受体信号
  • 批准号:
    8352879
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
糖尿病血管疾病中的 TNF-α 和 BMP2-WNT 信号转导
  • 批准号:
    8020994
  • 财政年份:
    2008
  • 资助金额:
    $ 38万
  • 项目类别:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
糖尿病血管疾病中的 TNF-α 和 BMP2-WNT 信号转导
  • 批准号:
    7762246
  • 财政年份:
    2008
  • 资助金额:
    $ 38万
  • 项目类别:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
糖尿病血管疾病中的 TNF-α 和 BMP2-WNT 信号转导
  • 批准号:
    7364683
  • 财政年份:
    2008
  • 资助金额:
    $ 38万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 38万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 38万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 38万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 38万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 38万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了